Role of Botulinum Toxin Type A in Migraine

Sharjeel Chaudhry
Additional contact information
Sharjeel Chaudhry: Dow International Dental College, Karachi, Pakistan

Biomedical Journal of Scientific & Technical Research, 2023, vol. 50, issue 3, 41629-41634

Abstract: This article focuses on the usage of Botox type A (BoNT-A) as a treatment for migraines in patients. Almost 10% of the global population suffers from migraines, with middle-aged and young women being the most prevalent users of BoNT-A. BoNT-A functions by blocking acetylcholine release, preventing neuro exocytosis, and causing selective nerve terminal targeting. It has been utilised to treat a variety of medical conditions, including focal dystonias, spasticity, muscle spasms, achalasia, and blepharospasm.

Keywords: Journals on Medical Drug and Therapeutics; Journals on Emergency Medicine; Physical Medicine and Rehabilitation; Journals on Infectious Diseases Addiction Science and Clinical Pathology; Open Access Clinical and Medical Journal; Journals on Biomedical Science; List of Open Access Medical Journal; Journals on Biomedical Engineering; Open Access Medical Journal; Biomedical Science Articles; Journal of Scientific and Technical Research (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.007947.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.007947.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:50:y:2023:i:3:p:41629-41634

DOI: 10.26717/BJSTR.2023.50.007947

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().